Antidote / dye
Methylthioninium chloride (methylene blue)
Brand names: Provayblue
Adult dose
Dose: Methaemoglobinaemia: 1–2 mg/kg IV slow over 5 min; repeat after 30–60 min if needed (max 7 mg/kg). Vasoplegia (refractory): 1–2 mg/kg IV
Route: IV
Frequency: PRN
Clinical pearls
- Drug-induced methaemoglobinaemia (e.g. dapsone, prilocaine, nitrites) when SpO2 reading misleadingly low
- Counsel re harmless blue urine
Contraindications
- G6PD deficiency (haemolysis)
- Severe renal impairment
- Hypersensitivity
- Concurrent serotonergic drugs (serotonin syndrome — caution)
Side effects
- Blue/green discolouration of urine and skin
- Dyspnoea
- Hypertension
- Methaemoglobinaemia at high doses (paradoxical)
- Hypersensitivity
Interactions
- SSRIs/SNRIs/MAOIs/triptans (serotonin syndrome)
Monitoring
- Methaemoglobin level
- ABG / co-oximetry
- BP
Reference: BNF; TOXBASE; NPIS; https://bnf.nice.org.uk/drugs/methylthioninium-chloride/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
- Syncope Assessment · ESC 2018 Syncope Guidelines; NICE NG109
- Acute Chest Pain · NICE CG95; ESC 2023 ACS Guidelines